T-cell Lymphomas
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of Ruxolitinib and Duvelisib in People With Lymphoma (NCT05010005) | Memorial Sloan Kettering Cancer Center | 2021-08-12 |
| Combination Therapy With Carfilzomib, Romidepsin, Lenalidomide in Patients With Relapsed or Refractory B- and T-cell Lymphomas (NCT02341014) | Memorial Sloan Kettering Cancer Center | 2015-01-02 |
| Study of Infusion of Blood Cells (Lymphocytes) to Stimulate the Immune System to Fight Leukemia/Lymphoma (NCT01685606) | Brown University | 2013-03-01 |
| A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL) (NCT00611208) | Virogen Biotechnology Inc. | 2008-01-01 |
| Orally Fludarabine, Adriamycin and Dexamethasone (FAD) in Newly Diagnosed Peripheral T-cell Lymphomas (PTCL) (NCT00840385) | Fudan University | 2007-11-01 |
Track T-cell Lymphomas automatically
Every clearance here is in the API, with alerts when new ones post.